Diffuse Large B-Cell Lymphoma Unclassifiable
3 clinical trials · Condition
◉ Watch Diffuse Large B-Cell Lymphoma Unclassifiable
| Record | Firm | Date |
|---|---|---|
| Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT04665765) | City of Hope Medical Center | 2021-01-18 |
| Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma (NCT03704714) | Northwestern University | 2018-11-20 |
| Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib (NCT02636322) | M.D. Anderson Cancer Center | 2016-03-29 |
Track Diffuse Large B-Cell Lymphoma Unclassifiable automatically
Every clearance here is in the API, with alerts when new ones post.